Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Feb 28, 2025 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.64%36.48B | 7.09%9.19B | -0.72%8.3B | 12.61%35.2B | 5.41%10.07B | 0.32%8.19B | 21.00%8.58B | 29.62%8.36B | 16.41%31.26B | 20.94%9.55B |
| Cost of revenue | 3.48%24.17B | 11.67%6.15B | 0.69%5.44B | 13.85%23.35B | 8.44%7.01B | -1.17%5.43B | 22.18%5.51B | 33.66%5.4B | 15.20%20.51B | 20.64%6.47B |
| Gross profit | 3.95%12.31B | -1.12%3.04B | -3.29%2.86B | 10.25%11.84B | -0.95%3.05B | 3.39%2.76B | 18.95%3.07B | 22.85%2.96B | 18.81%10.74B | 21.59%3.08B |
| Operating expense | 8.47%11.4B | 10.05%2.86B | 10.48%2.75B | 14.42%10.51B | 1.69%2.83B | 13.99%2.59B | 24.36%2.6B | 22.05%2.49B | 18.71%9.19B | 33.09%2.78B |
| Staff costs | 8.43%4.5B | ---- | ---- | 9.71%4.15B | ---- | ---- | ---- | ---- | 14.18%3.78B | ---- |
| Selling and administrative expenses | 14.55%2.96B | ---- | ---- | 19.40%2.58B | ---- | ---- | ---- | ---- | 28.80%2.16B | ---- |
| -Selling and marketing expense | 38.99%416.47M | ---- | ---- | 19.84%299.65M | ---- | ---- | ---- | ---- | 30.87%250.04M | ---- |
| -General and administrative expense | 11.34%2.54B | ---- | ---- | 19.34%2.28B | ---- | ---- | ---- | ---- | 28.54%1.91B | ---- |
| Depreciation and amortization | 11.20%422.24M | ---- | ---- | 43.05%379.71M | ---- | ---- | ---- | ---- | 14.12%265.45M | ---- |
| -Depreciation | 12.54%381.66M | ---- | ---- | 50.81%339.13M | ---- | ---- | ---- | ---- | 17.10%224.87M | ---- |
| -Amortization | 0.00%40.58M | ---- | ---- | 0.00%40.58M | ---- | ---- | ---- | ---- | 0.00%40.58M | ---- |
| Rent and land expenses | 3.72%1.73B | ---- | ---- | 5.96%1.67B | ---- | ---- | ---- | ---- | 5.00%1.57B | ---- |
| Other operating expenses | 3.45%1.79B | ---- | ---- | 23.48%1.73B | ---- | ---- | ---- | ---- | 38.00%1.4B | ---- |
| Operating profit | -31.63%911.92M | -62.64%176.62M | -76.34%111.11M | -14.34%1.33B | -25.29%225.33M | -57.78%166.24M | -4.06%472.78M | 27.24%469.54M | 19.46%1.56B | -32.33%301.59M |
| Net non-operating interest income (expenses) | -50.23%-27.01M | -37.42%-6.39M | -38.49%-5.53M | 10.67%-17.98M | 6.74%-4.98M | 12.68%-4.36M | 6.72%-4.65M | 17.03%-3.99M | -3.96%-20.13M | -6.88%-5.34M |
| Non-operating interest income | -26.35%1.62M | -40.81%364K | -38.73%405K | -9.42%2.2M | -34.96%426K | -18.99%499K | 4.95%615K | 15.36%661K | 7.24%2.43M | 21.52%655K |
| Non-operating interest expense | 41.88%28.63M | 28.28%6.75M | 27.52%5.93M | -10.53%20.18M | -9.82%5.41M | -13.37%4.86M | -5.50%5.26M | -13.58%4.65M | 4.30%22.56M | 8.30%6M |
| Net investment income | 32.27%1.87M | -3.93%1.42M | 9.90%733K | 0 | 81.30%1.47M | 61.89%667K | ||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -112.01%-7.64M | -65.34%10.64M | -68.39%12.93M | 189.13%63.6M | -123.35%-14.17M | 0.16%6.15M | 352.63%30.7M | 165.42%40.91M | 610.89%22M | 59.19%-6.34M |
| Special income (charges) | 48.64%-160.52M | 33.17%-554K | -2.51M | -1,567.05%-312.56M | -1,661.36%-311.73M | 0 | -697.12%-829K | 0 | 85.26%-18.75M | 85.82%-17.7M |
| Less:Other special charges | 59.12%6.45M | --554K | --2.51M | -20.47%4.06M | -20.30%3.23M | --0 | ---- | ---- | -1.03%5.1M | 46.97%4.05M |
| Less:Write off | -50.06%154.07M | ---- | ---- | 2,160.23%308.5M | ---- | ---- | ---- | ---- | -88.82%13.65M | ---- |
| Other non-operating income (expenses) | -5.34%40.76M | -34.89%9.17M | -18.08%11.86M | -0.42%43.06M | 21.24%12.99M | -86.22%1.52M | 6.95%14.08M | 73.30%14.47M | 33.41%43.24M | 32.90%10.72M |
| Income before tax | -31.68%759.37M | -62.88%190.36M | -75.46%127.86M | -29.88%1.11B | -132.38%-91.83M | -58.23%169.55M | 0.85%512.76M | 34.60%520.93M | 32.82%1.58B | -8.16%283.58M |
| Income tax | -52.52%257.78M | -53.69%80.41M | -74.24%64.29M | -6.84%542.94M | -57.90%48.98M | -50.61%70.78M | 4.83%173.65M | 58.41%249.53M | 290.42%582.83M | 120.33%116.36M |
| Net income | -11.77%501.59M | -67.58%109.94M | -76.58%63.57M | -43.27%568.47M | -184.21%-140.81M | -62.38%98.77M | -1.08%339.12M | 18.26%271.39M | -33.16%1B | -81.02%167.22M |
| Net income continuous operations | -11.77%501.59M | -67.58%109.94M | -76.58%63.57M | -43.27%568.47M | -184.21%-140.81M | -62.38%98.77M | -1.08%339.12M | 18.26%271.39M | -33.16%1B | -81.02%167.22M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -11.77%501.59M | -67.58%109.94M | -76.58%63.57M | -43.27%568.47M | -184.21%-140.81M | -62.38%98.77M | -1.08%339.12M | 18.26%271.39M | -33.16%1B | -81.02%167.22M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -11.77%501.59M | -67.58%109.94M | -76.58%63.57M | -43.27%568.47M | -184.21%-140.81M | -62.38%98.77M | -1.08%339.12M | 18.26%271.39M | -33.16%1B | -81.02%167.22M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -10.18%7.94 | -66.79%1.74 | -75.95%1.01 | -43.11%8.84 | -182.24%-2.13 | -62.50%1.53 | -2.06%5.24 | 19.32%4.2 | -30.28%15.54 | -80.30%2.59 |
| Diluted earnings per share | -10.18%7.94 | -66.15%1.7395 | -75.95%1.01 | -43.11%8.84 | -188.17%-2.2344 | -61.63%1.53 | -1.30%5.1388 | 19.32%4.2 | -30.28%15.54 | -80.73%2.534 |
| Dividend per share | 0.00%4 | 0 | 0 | 33.33%4 | 33.33%4 | 0 | 0 | 0 | 200.00%3 | 200.00%3 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |